Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, May 1, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Real Estate
SGA’s Science & Technology Director Matthew Fickett to Speak at Life Sciences Facilities Summit
Life Sciences Times
-
June 2, 2021
0
Real Estate
Cushman’s East Region Life Sciences Lead Dan Hackett to Speak at Life Sciences Summit on June 9
Life Sciences Times
-
June 2, 2021
0
Biotech
Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth
Life Sciences Times
-
June 1, 2021
0
People on the Move
Ambys Medicines Appoints Ronald Park, M.D., Chief Executive Officer
Life Sciences Times
-
June 1, 2021
0
Life Sciences
Agilent Presents Thought Leader Award to Professor Chris Elliott
Life Sciences Times
-
June 1, 2021
0
People on the Move
Selexis Appoints Roland Hoffmann-Hecht, PhD, as Chief Business Officer
Life Sciences Times
-
June 1, 2021
0
Venture Capital
Solesis Completes Investment from Altaris Capital Partners
Life Sciences Times
-
June 1, 2021
0
Venture Capital
Accelerator Life Science Partners’ Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc.
Life Sciences Times
-
May 28, 2021
0
Life Sciences
CUBIO Innovation Center and CreaGen Enter Into Partnership Agreement
Life Sciences Times
-
May 28, 2021
0
Pharma
Transgene and BioInvent Receive IND Approval from the U.S. FDA for BT-001, a Novel Oncolytic Virus for the Treatment of Solid Tumors
Life Sciences Times
-
May 27, 2021
0
1
...
780
781
782
...
831
Page 781 of 831
Most Popular
Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board
May 1, 2026
SK Capital Completes Sale of Noramco Group Businesses to Siegfried
May 1, 2026
GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients
May 1, 2026
Seaport Therapeutics Prices Upsized IPO at $18 Per Share
May 1, 2026
Load more
Recent Comments
Recent Comments